Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayuki Sumiyoshi

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 26, 2017
CLINICAL OUTCOMES OF EXTERNAL-BEAM RADIOTHERAPY COMBINED WITH NEOADJUVANT ANDROGEN DEPRIVATION THERAPY FOR HIGH-RISK PROSTATE CANCERTakuya Okada, Kenji Takayama, Masaki Kokubo, et al.
Cancer Science|November 3, 2023
Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamideTakashi Matsuoka, Aiko Sugiyama, Yoshifumi Miyawaki, et al.
Annals of Surgical Oncology|April 6, 2026
Stage-Specific Prognostic Impact of Tumor Location in Upper Tract Urothelial Carcinoma: A Propensity Score-Matched AnalysisShigeki Koterazawa, Toru Kanno, Yuki Kita, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 4, 2024
[Renal Pelvic Cancer with Inferior Vena Cava Tumor Thrombus: A Case Report]Hitoshi Yokozeki, Takayuki Sumiyoshi, Takehiro Yamane, et al.
EJNMMI Research|June 2, 2026
GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Atsushi Doi, et al.
Scientific Reports|October 24, 2019
eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNAKei Mizuno, Shusuke Akamatsu, Takayuki Sumiyoshi, et al.
Cancer Science|May 7, 2021
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13Kosuke Okasho, Kei Mizuno, Tomohiro Fukui, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2026
Circulating Tumor DNA Genomic Profiling in <sup>223</sup>Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 StudyMasaki Shiota, Maki Fujiwara, Takayuki Sumiyoshi, et al.
Iscience|October 13, 2025
Urothelial collective-gliding response acts as a toll-like receptor 4-associated defense mechanismNing Zhang, Takeshi Sano, Katsuhiro Ito, et al.
World Journal of Urology|June 2, 2026
Applying classification of intraoperative adverse events (ClassIntra) to robot-assisted radical prostatectomy to predict the risk of postoperative adverse eventsShinya Somiya, Ryoichi Saito, Toru Kanno, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 26, 2017
CLINICAL OUTCOMES OF EXTERNAL-BEAM RADIOTHERAPY COMBINED WITH NEOADJUVANT ANDROGEN DEPRIVATION THERAPY FOR HIGH-RISK PROSTATE CANCERTakuya Okada, Kenji Takayama, Masaki Kokubo, et al.
Cancer Science|November 3, 2023
Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamideTakashi Matsuoka, Aiko Sugiyama, Yoshifumi Miyawaki, et al.
Annals of Surgical Oncology|April 6, 2026
Stage-Specific Prognostic Impact of Tumor Location in Upper Tract Urothelial Carcinoma: A Propensity Score-Matched AnalysisShigeki Koterazawa, Toru Kanno, Yuki Kita, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 4, 2024
[Renal Pelvic Cancer with Inferior Vena Cava Tumor Thrombus: A Case Report]Hitoshi Yokozeki, Takayuki Sumiyoshi, Takehiro Yamane, et al.
EJNMMI Research|June 2, 2026
GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Atsushi Doi, et al.
Scientific Reports|October 24, 2019
eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNAKei Mizuno, Shusuke Akamatsu, Takayuki Sumiyoshi, et al.
Cancer Science|May 7, 2021
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13Kosuke Okasho, Kei Mizuno, Tomohiro Fukui, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2026
Circulating Tumor DNA Genomic Profiling in <sup>223</sup>Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 StudyMasaki Shiota, Maki Fujiwara, Takayuki Sumiyoshi, et al.
Iscience|October 13, 2025
Urothelial collective-gliding response acts as a toll-like receptor 4-associated defense mechanismNing Zhang, Takeshi Sano, Katsuhiro Ito, et al.
World Journal of Urology|June 2, 2026
Applying classification of intraoperative adverse events (ClassIntra) to robot-assisted radical prostatectomy to predict the risk of postoperative adverse eventsShinya Somiya, Ryoichi Saito, Toru Kanno, et al.
Pageof 8